Bulletin
Investor Alert

New York Markets After Hours

Clovis Oncology Inc.

NAS: CLVS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201295534/composite

$

8.57

Change

0.00 0.00%

Volume

Volume 3,362

Jan 27, 2020, 4:41 p.m.

Real time quotes

/zigman2/quotes/201295534/composite

Today's close

$ 8.93

$ 8.57

Change

-0.36 -3.98%

Day low

Day high

$8.35

$8.77

Open
Open: 8.54

52 week low

52 week high

$2.93

$32.05

Open

Market cap

$647.89M

Average volume

12.39M

P/E ratio

N/A

Rev. per Employee

$203,821

EPS

-7.51

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/clvs

MarketWatch News on CLVS

  1. Pfizer’s New Strategy Makes It Worth Another Look

    2:52 p.m. Dec. 4, 2019

    - Barron's Online

  2. Three momentum stocks to watch after company earnings reports

    12:50 p.m. Nov. 22, 2019

    - Harry Boxer

  3. Clovis Oncology stock price target cut to $8 from $12 at Evercore ISI

    7:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  4. Clovis Oncology downgraded to in line from outperform at Evercore ISI

    7:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  5. The Dow Is Up Because There’s a Little More Hope About Trade

    8:16 a.m. Sept. 24, 2019

    - Barron's Online

  6. Clovis Oncology Falls After Analyst Blasts New Licensing Deal

    8:02 a.m. Sept. 24, 2019

    - Barron's Online

  7. Clovis Oncology downgraded to market perform from outperform at SVB Leerink

    7:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  8. Clovis Oncology stock price target cut to $10 from $21 at SVB Leerink

    7:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  9. Clovis Oncology stock price target cut to $22 from $40 at SVB Leerink

    7:27 a.m. Aug. 2, 2019

    - Tomi Kilgore

  10. The Dow is tumbling as recession fears meet the trade war

    10:56 a.m. May 29, 2019

    - Barron's Online

  11. Clovis Oncology Shares Drop on Cancer Drug Potential

    9:08 a.m. May 29, 2019

    - Barron's Online

  12. The Dow Drops 410 Points Because Trade Worries Are Back

    12:22 p.m. Dec. 4, 2018

    - Barron's Online

  13. GlaxoSmithKline Stock Slumps on News of Tesaro Deal

    10:51 a.m. Dec. 3, 2018

    - Barron's Online

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/clvs

Other News on CLVS

  1. Netflix And Dow Heavyweights Into The Earnings Confessional

    8:23 a.m. Jan. 18, 2020

    - Seeking Alpha

  2. NIO, NVAX among premarket gainers

    9:12 a.m. Jan. 15, 2020

    - Seeking Alpha

  3. Clovis: Evaluating The Prospects Of A Possible Acquisition

    9:27 a.m. Jan. 9, 2020

    - Seeking Alpha

  4. Clovis Oncology announces debt refinancing

    8:25 a.m. Jan. 7, 2020

    - Seeking Alpha

  5. Clovis Oncology +3% on debt refinancing

    8:25 a.m. Jan. 7, 2020

    - Seeking Alpha

  6. Corporate News for Dec 18, 2019

    10:31 a.m. Dec. 18, 2019

    - Zacks.com

  7. UL, CLVS among premarket losers

    9:12 a.m. Dec. 17, 2019

    - Seeking Alpha

  8. Waiting On PARP Traction For Clovis; Competition A Concern

    1:15 a.m. Dec. 11, 2019

    - Seeking Alpha

  9. Clovis Oncology: Best In Class

    11:51 a.m. Dec. 9, 2019

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/clvs

Press Releases on CLVS

  1. Ovarian Cancer Drugs Market Global Review: Actions that Could Prove Costly

    12:41 p.m. Jan. 25, 2020

    - HTF Market Intelligence

  2. Clovis Oncology Announces Debt Refinancing Transaction

    7:26 a.m. Jan. 7, 2020

    - BusinessWire - BZX

  3. Colorado Life Sciences Companies Raise $750 Million in 2019

    10:00 a.m. Dec. 17, 2019

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.